These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15035206)

  • 1. [Glucocorticoid-induced osteoporosis--epidemiology and pathogenesis].
    Suzuki Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():668-72. PubMed ID: 15035206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies on glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):142-151. PubMed ID: 16646164
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of glucocorticoid on bone-forming and bone-resorbing cells].
    Hakeda Y
    Clin Calcium; 2006 Nov; 16(11):1817-22. PubMed ID: 17079848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for the diagnosis and treatment of glucocorticoid-induced osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():663-7. PubMed ID: 15035205
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation.
    Ishida Y; Heersche JN
    J Bone Miner Res; 1998 Dec; 13(12):1822-6. PubMed ID: 9844099
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of glucocorticoid-induced osteoporosis.
    Canalis E
    Curr Opin Rheumatol; 2003 Jul; 15(4):454-7. PubMed ID: 12819474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.
    Weinstein RS; Chen JR; Powers CC; Stewart SA; Landes RD; Bellido T; Jilka RL; Parfitt AM; Manolagas SC
    J Clin Invest; 2002 Apr; 109(8):1041-8. PubMed ID: 11956241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of glucocorticoid action in bone cells.
    Delany AM; Dong Y; Canalis E
    J Cell Biochem; 1994 Nov; 56(3):295-302. PubMed ID: 7876321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of glucocorticoid action in bone.
    Canalis E; Delany AM
    Ann N Y Acad Sci; 2002 Jun; 966():73-81. PubMed ID: 12114261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats.
    Fujita Y; Watanabe K; Uchikanbori S; Maki K
    Am J Orthod Dentofacial Orthop; 2011 Mar; 139(3):e267-77. PubMed ID: 21392671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
    Chotiyarnwong P; McCloskey EV
    Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
    Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
    Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of mevalonate pathway in osteogenic cells].
    Ishimi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acceleration of bone formation].
    Nakamura T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():317-20. PubMed ID: 16279654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorders of calcium and bone metabolism in glucocorticoid treatment].
    Kruse K; Büsse M; Kracht U; Kruse U; Wohlfart K
    Monatsschr Kinderheilkd; 1988 May; 136(5):237-42. PubMed ID: 2841591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
    Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
    J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.